Independent Investors Inc Abb Vie Inc. Transaction History

Independent Investors Inc

$501 Million
Q4 2024

A detailed history of Independent Investors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Independent Investors Inc holds 45,388 shares of ABBV stock, worth $9.12 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares

45,388

Previous 45,388 -0.0%

Holding current value

$9.12 Million

Previous $8.96 Million 10.02%

% of portfolio

1.61%

Previous 1.83%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	SELL	$132.51 - $164.9 $3,445 - $4,287	-26 Reduced 0.06%	45,388 $6.12 Million
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $3,489 - $4,002	26 Added 0.06%	45,414 $6.1 Million
Q2 2022 Jul 13, 2022	SELL	$137.62 - $174.96 $320,654 - $407,656	-2,330 Reduced 4.88%	45,388 $6.95 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $32,229 - $40,779	-300 Reduced 0.62%	47,718 $6.46 Million
Q3 2021 Oct 28, 2021	SELL	$106.4 - $120.78 $79,800 - $90,585	-750 Reduced 1.54%	48,018 $5.18 Million
Q4 2020 Jan 27, 2021	SELL	$80.49 - $108.67 $136,833 - $184,739	-1,700 Reduced 3.37%	48,768 $5.23 Million
Q2 2020 Jul 09, 2020	BUY	$73.37 - $98.18 $349,828 - $468,122	4,768 Added 10.43%	50,468 $4.95 Million
Q1 2020 Apr 06, 2020	SELL	$64.5 - $97.79 $12,900 - $19,558	-200 Reduced 0.44%	45,700 $3.48 Million
Q4 2019 Jan 15, 2020	SELL	$72.13 - $90.25 $46,884 - $58,662	-650 Reduced 1.4%	45,900 $4.06 Million
Q3 2019 Oct 31, 2019	SELL	$62.98 - $75.72 $12,596 - $15,144	-200 Reduced 0.43%	46,550 $3.52 Million
Q2 2019 Jul 18, 2019	SELL	$65.7 - $83.98 $262,800 - $335,920	-4,000 Reduced 7.88%	46,750 $3.4 Million
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $185,136 - $217,896	-2,400 Reduced 4.52%	50,750 $4.09 Million
Q4 2018 Jan 14, 2019	SELL	$77.85 - $96.01 $93,420 - $115,212	-1,200 Reduced 2.21%	53,150 $4.9 Million
Q3 2018 Nov 06, 2018	SELL	$88.91 - $98.84 $4,445 - $4,942	-50 Reduced 0.09%	54,350 $5.14 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $9,201 - $12,321	-100 Reduced 0.18%	54,400 $5.15 Million
Q3 2017 Oct 24, 2017	BUY	$69.85 - $89.22 $3.81 Million - $4.86 Million	54,500	54,500 $4.84 Million

Others Institutions Holding ABBV

# of Institutions

4,092

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Investors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Independent Investors Inc with notifications on news.

Account

Independent Investors Inc Abb Vie Inc. Transaction History